Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Pfizer (PFE) reports Q2 earnings before market open on July 28. Can it maintain soaring earnings and revenue growth amid the global COVID-19 pandemic?

Pfizer (PFE) reports Q4 earnings in the morning on Feb. 8. Will demand for its COVID-19 vaccine remain strong enough to keep profits and revenue rising?

Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Pharmaceutical giant Pfizer (PFE) is set to release its second quarter Fiscal 2024 results on July 30. The Street expects Pfizer to post adjusted earnings per share (EPS) of $0.46 on revenue of ...

Pfizer’s PFE Q3 earnings report on November 1 will give insight into the company’s ability to sustain growth from its Covid-19 vaccines. Vaccinations gave PFE a boost during the pandemic with ...

Our interactive dashboard analysis of Pfizer’s FY 2024Q3 Earnings Preview has more details on the company’s revenues and earnings for the quarter.